Soluble Mimetics of Human Immunodeficiency Virus Type 1 Viral Spikes Produced by Replacement of the Native Trimerization Domain with aHeterologous Trimerization Motif: Characterization and Ligand Binding Analysis
-
Published:2005-08
Issue:15
Volume:79
Page:9954-9969
-
ISSN:0022-538X
-
Container-title:Journal of Virology
-
language:en
-
Short-container-title:J Virol
Author:
Pancera Marie1, Lebowitz Jacob2, Schön Arne3, Zhu Ping4, Freire Ernesto3, Kwong Peter D.1, Roux Kenneth H.4, Sodroski Joseph5, Wyatt Richard1
Affiliation:
1. Vaccine Research Center, NIH, Bethesda, Maryland 20892 2. Division of Bioengineering and Physical Science, NIH, Bethesda, Maryland 20892 3. Department of Biology, The Johns Hopkins University, Baltimore, Maryland 21218 4. Department of Biological Science and Institute of Molecular Biophysics, Florida State University, Tallahassee, Florida 32306 5. Dana Farber Cancer Institute, Boston, Masssachusetts 02115
Abstract
ABSTRACT
The
human immunodeficiency virus type 1 (HIV-1) exterior envelope
glycoprotein, gp120, mediates binding to the viral receptors and, along
with the transmembrane glycoprotein gp41, is a major target for
neutralizing antibodies. We asked whether replacing the gp41
fusion/trimerization domain with a stable trimerization motif might
lead to a more stable gp120 trimer that would be amenable to structural
and immunologic analysis. To obtain stable gp120 trimers, a
heterologous trimerization motif, GCN4, was appended to the C terminus
of YU2gp120. Biochemical analysis indicated that the gp120-GCN4 trimers
were superior to gp140 molecules in their initial homogeneity, and
trilobed structures were observable by electron microscopy. Biophysical
analysis of gp120-GCN4 trimers by isothermal titration calorimetry
(ITC) and ultracentrifugation analyses indicated that most likely two
molecules of soluble CD4 could bind to one gp120-GCN4 trimer. To
further examine restricted CD4 stoichiometric binding to the gp120-GCN4
trimers, we generated a low-affinity CD4 binding trimer by introducing
a D457V change in the CD4 binding site of each gp120 monomeric subunit.
The mutant trimers could definitively bind only one soluble CD4
molecule, as determined by ITC and sedimentation equilibrium
centrifugation. These data indicate that there are weak interactions
between the gp120 monomeric subunits of the GCN4-stabilized trimers
that can be detected by low-affinity ligand sensing. By similar
analysis, we also determined that removal of the variable loops V1, V2,
and V3 in the context of the gp120-GCN4 proteins allowed the binding of
three CD4 molecules per trimer. Interestingly, both the gp120-GCN4
variants displayed a restricted stoichiometry for the CD4-induced
antibody 17b of one antibody molecule binding per trimer. This
restriction was not evident upon removal of the variable loops V1 and
V2 loops, consistent with conformational constraints in the wild-type
gp120 trimers and similar to those inherent in the functional Env
spike. Thus, the gp120-GCN4 trimers demonstrate several properties that
are consistent with some of those anticipated for gp120 in the context
of the viral
spike.
Publisher
American Society for Microbiology
Subject
Virology,Insect Science,Immunology,Microbiology
Reference75 articles.
1. Adis International Ltd. 2003. HIV gp120 vaccine - VaxGen: AIDSVAX, AIDSVAX B/B, AIDSVAX B/E, HIV gp120 vaccine - Genentech, HIV gp120 vaccine AIDSVAX - VaxGen, HIV vaccine AIDSVAX - VaxGen.Drugs R D4:249-253. 2. Barnett, S. W., S. Rajasekar, H. Legg, B. Doe, D. H. Fuller, J. R. Haynes, C. M. Walker, and K. S. Steimer. 1997. Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit. Vaccine15:869-873. 3. Belshe, R. B., G. J. Gorse, M. J. Mulligan, T. G. Evans, M. C. Keefer, J. L. Excler, A. M. Duliege, J. Tartaglia, W. I. Cox, J. McNamara, K. L. Hwang, A. Bradney, D. Montefiori, K. J. Weinhold, et al. 1998. Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers. AIDS12:2407-2415. 4. Berman, P. W., T. J. Gregory, L. Riddle, G. R. Nakamura, M. A. Champe, J. P. Porter, F. M. Wurm, R. D. Hershberg, E. K. Cobb, and J. W. Eichberg. 1990. Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160. Nature345:622-625. 5. Comprehensive Cross-Clade Neutralization Analysis of a Panel of Anti-Human Immunodeficiency Virus Type 1 Monoclonal Antibodies
Cited by
62 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|